MedPath

Colorectal Cancer in Crohn's Disease

Conditions
Colorectal Cancer
Inflammatory Bowel Diseases
Crohn Disease
Interventions
Procedure: Total proctocolectomy
Procedure: Total colectomy
Procedure: Segmental colectomy
Registration Number
NCT04654494
Lead Sponsor
University of Rome Tor Vergata
Brief Summary

Retrospective multicentre study. All patients with a diagnosis of Crohn's disease (CD) and operated for colorectal cancer (CRC) between 01/01/2010 and 01/01/2020 will be included in the dataset.

Data will include preoperative, intraoperative and postoperative variables, with long term follow up when feasible.

The study will focus on a comparison between patients treated with total proctocolectomy (TPC) and patients treated with subtotal colectomy (STC) or segmental resection (SR).

Primary endpoints will be oncologic outcomes, postoperative morbidity and mortality. Secondary endpoints include quality of life (QoL).

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
70
Inclusion Criteria
  • All patients with a diagnosis of Crohn's disease and concomitant primary colorectal cancer who underwent surgery in an expert centre between 01/01/2010 and 01/01/2020
Exclusion Criteria
  • Patients who underwent non-oncologic segmental resection will be excluded from outcome analysis.
  • Patients with known genetic colorectal cancer syndromes (eg. Familial Adenomatous Polyposis, Hereditary Non-Polyposis ColoRectal Cancer Syndrome)

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Chron's disease patients with colorectal cancerTotal proctocolectomyThis group of patients with Chron's disease have been diagnosed with colorectal cancer and treated surgically
Chron's disease patients with colorectal cancerTotal colectomyThis group of patients with Chron's disease have been diagnosed with colorectal cancer and treated surgically
Chron's disease patients with colorectal cancerSegmental colectomyThis group of patients with Chron's disease have been diagnosed with colorectal cancer and treated surgically
Primary Outcome Measures
NameTimeMethod
Overall Survival5 years

percentage of patients alive

disease free survival5 years

percentage of patients disease free

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Policlinico Tor Vergata

🇮🇹

Roma, RM, Italy

© Copyright 2025. All Rights Reserved by MedPath